Nurefsan Sariipek, MD^1*, Kseniia R. Safina, PhD^1*, Corey Cutler², Vincent T. Ho, MD^2,3*, John Koreth, MD, MBBS, PhD, DPhil², Coleman Lindsley, MD, PhD², Marlise R. Luskin, MD³, Jacqueline S. Garcia, MD³, Doreen Hearsey^4*, Wesley S Lu, BS^5*, Shuqiang Li, PhD^5*, Kenneth J. Livak, PhD^5*, Gabriel K. Griffin, MD^6*, Robert J. Soiffer, MD³, Jerome Ritz, MD³, Catherine J Wu, MD³, Joseph H. Antin, MD², Andrew A. Lane, MD, PhD³, Peter Van Galen, PhD¹ and Mahasweta Gooptu, MD⁷

¹Division of Hematology, Brigham and Women's Hospital, Boston, MA
²Dana-Farber Cancer Institute, Boston, MA
³Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁴Pasquarello Tissue Bank Connel and O'Reilly Families Cell Manipulation Core, Dana-Farber Cancer Institute, Boston, MA
⁵Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA
⁶Department of Pathology, Dana-Farber Cancer Institute, Boston, MA
⁷Medical Oncology, Dana-Farber Cancer Instititute, Boston, MA

Joseph Pidala, MD, PhD^1*, Shernan G. Holtan, MD², Kelly Walton^3*, Jongphil Kim, PhD^4*, Hany Elmariah, MD, MS⁵, Asmita Mishra, MD, MBA⁵, Nelli Bejanyan, MD^5*, Taiga Nishihori, MD⁵, Farhad Khimani, MBBS^5*, Lia Perez, MD^5*, Rawan Faramand, MD⁵, Marco Davila, MD, PhD⁶, Claudio Anasetti, MD^5*, Daniel Weisdorf, MD³, Bruce R Blazar, MD⁷, Jeffrey S Miller, MD⁸, Veronika Bachanova, MD, PhD⁹, Najla El Jurdi, MD¹⁰ and Brian C Betts, MD^3*

¹H. Lee Moffitt Cancer Ctr., Tampa, FL
²Department of Medicine, University of Minnesota, Minneapolis, MN
³University of Minnesota, Minneapolis, MN
⁴Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL
⁵Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
⁶Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
⁷Division of Pediatric Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN
⁸Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN
⁹Umn Center For Allied Health Programs, Minneapolis, MN
¹⁰Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, minneapolis, MN

Esteban Arrieta-Bolanos^1,2*, Edouard F. Bonneville, PhD^3,4*, Marie Robin, MD, PhD^5*, Tobias Gedde-Dahl, MD^6*, Urpu Salmenniemi^7*, Nicolaus Kröger, MD^8*, Ibrahim Yakoub-Agha, MD, PhD^9*, Charles Crawley, MD^10*, Goda Choi, MD^11*, Annoek E. C. Broers, MD^12*, Edouard Forcade, MD, PhD^13*, Martin Carre, MD^14*, Xavier Poiré, MD, PhD^15*, Anne Huynh, MD^16*, Péter Reményi, MD^17*, Stig Lenhoff, MD^18*, Fabio Ciceri^19*, Eleni Tholouli, MD^20*, Thomas Schröder, MD^21*, Eric Deconinck²², Kristina Elisabet Carlson, MD, PhD²³, Liesbeth C. de Wreede, PhD^3*, Jorinde D. Hoogenboom^4*, Florent Malard, MD, PhD^24*, Annalisa Ruggeri, MD, PhD^19* and Katharina Fleischhauer, MD^2,25*

¹Institute for Experimental Cellular Therapy, Essen University Hospital, Essen, Germany
²German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, Essen, Germany
³Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, Netherlands
⁴EBMT Leiden Study Unit, Leiden, Netherlands
⁵Department of Hematology, Transplantation Division, Hopital Saint-Louis, Paris Cedex 10, France
⁶Oslo University Hospital, Rikshospitalet, Clinic for Cancer Medicine, Hematology Department, Section for Stem Cell Transplantation, Oslo, Norway
⁷Dept of Hematology, Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki, Helsinki, Finland
⁸University Medical Center Hamburg, Hamburg, Germany
⁹CHU de Lille, Université de Lille, INSERM U1286, Infinite, 59000, Lille, France
¹⁰Addenbrookes Hospital, Cambridge, United Kingdom
¹¹University of Groningen, University Medical Center Groningen (UMCG), Groningen, Netherlands
¹²Erasmus MC Cancer Institute, Rotterdam, Netherlands
¹³Service d'Hématologie Clinique et Thérapie Cellulaire, CHU Bordeaux, Hopital Haut-Leveque, Pessac, France
¹⁴Clinical Hematology Department, CHU Grenoble Alpes - Université Grenoble Alpes, Grenoble, France
¹⁵Section of Hematology, Institut Roi Albert II, Cliniques Universitaires St-Luc, Brussels, Belgium
¹⁶Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France
¹⁷Department of Hematology and Stem Cell Transplantation, South-Pest Central Hospital, Budapest, Hungary
¹⁸Skanes University Hospital, Lund, Sweden
¹⁹Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy
²⁰Manchester Royal Infirmary, Clinical Haematology Department, Manchester, United Kingdom
²¹Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, Essen, Germany
²²Besançon University Hospital, Besançon, France
²³Department of Medical Sciences, University Hospital Uppsala, Uppsala, Sweden
²⁴Department of Clinical Hematology and Cellular Therapy, Sorbonne University, Saint Antoine Hospital, Assistance Publique - Hôpitaux de Paris, INSERM UMRs 938, Centre de Recherche Saint-Antoine (CRSA), PARIS, France
²⁵Institute for Experimental Cellular Therapy, University Hospital Essen, Essen, Germany

Olaf Penack, MD^1*, Mouad Abouqateb^2*, Christophe Peczynski^2*, William Boreland^3*, Zafer Gulbas, MD^4*, Tobias Gedde-Dahl, MD^5*, Cristina Castilla-Llorente, MD^6*, Nicolaus Kröger, MD^7*, Matthias Eder^8*, Alessandro Rambaldi, M.D.⁹, Francesca Bonifazi^10*, Igor Wolfgang Blau, MD, PhD^11*, Matthias Stelljes, MD¹², Peter Dreger, MD¹³, Ivan Sergeevich Moiseev, MD^14*, Helene Schoemans^15*, Christian Koenecke, MD¹⁶ and Zinaida Peric, MD PhD^17*

¹Department of Hematology, Oncology, and Cancer Immunology, Charité Universitätsmedizin Berlin, Campus Virchow Klinik, Berlin, Germany
²EBMT Office, Paris, France
³EBMT Paris study office / CEREST-TC, Hôpital Saint Antoine, Sorbonne University, Paris, France
⁴Anadolu Health Center Affiliated John Hopkins, Kocaeli, Gebze, TUR
⁵Oslo University Hospital, Rikshospitalet, Clinic for Cancer Medicine, Hematology Department, Section for Stem Cell Transplantation, Oslo, Norway
⁶Department of Hematology, Gustave Roussy Cancer Campus, Villejuif, France
⁷University Medical Center Hamburg, Hamburg, Germany
⁸Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
⁹Department of Hematology, ASST Papa Giovanni XXIII, Bergamo, ITA
¹⁰Bologna University, Bologna, NA, ITA
¹¹Medizinische Klinik m. S. Hämatologie, Onkologie und Tumorimmunologie, Berlin, Germany
¹²University of Muenster, Muenster, Germany
¹³Universitätsklinikum, Heidelberg, Germany
¹⁴RM Gorbacheva Research Institute, Pavlov University, Saint-Petersburg, Russian Federation
¹⁵University Hospitals Leuven and KU Leuven, Leuven, Belgium
¹⁶Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, NDS, Germany
¹⁷University Hospital Center Rebro, Zagreb, Croatia

Jonas Wißkirchen^*, Diana Wolff^*, Isabelle Ries^*, Oliver Kriege^*, Pascal Wölfinger^*, Beate Hauptrock, MD^*, Matthias Theobald, MD and Eva-Maria Wagner Drouet^*

Department of Internal Medicine III, University Medical Center Mainz, Mainz, Germany

Arnon Nagler, MD¹, Myriam Labopin^2*, Thomas Schroeder^3*, Rose-Marie Hamladji^4*, Laimonas Griskevicius^5*, Urpu Salmenniemi^6*, Alessandro Rambaldi, M.D.⁷, Stephan Mielke, MD⁸, Aleksandr Kulagin Sr.^9*, Jakob R. Passweg, MD, MS¹⁰, Peter Dreger, MD¹¹, Tobias Gedde-Dahl, MD^12*, Edouard Forcade, MD, PhD^13*, Grzegorz Helbig^14*, Matthias Stelljes, MD¹⁵, Cristina Castilla-Llorente, MD^16*, Alexandros Spyridonidis^17*, Bipin N. Savani, MD¹⁸, Eolia Brissot^19*, Fabio Ciceri, MD^20* and Mohamad Mohty, MD, PhD^21,22

¹Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel
²EBMT Statistical Unit, Sorbonne University, Saint-Antoine Hospital, AP-HP, INSERM UMRs 938, Paris, France
³Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany
⁴Centre Pierre et Marie Curie, Algiers, Algeria
⁵Vilnius University Hospital Santariskiu Clinics, Vilnius, Na, LTU
⁶Dept of Hematology, Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki, Helsinki, Finland
⁷Hematology and Bone Marrow Transplant Unit, Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
⁸Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska Institute & University Hospital, Stockholm, Stockholms Laen, Sweden
⁹b. First State Pavlov Medical University of St. Petersburg, Raisa Gorbacheva Memorial Research Institute for Paediatric Oncology, Hematology, and Transplantation, St-Petersburg, Russia, St. Petersburg, RUS
¹⁰Department of Hematology University Hospital of Basel, Basel, Switzerland
¹¹University of Heidelberg, Heidelberg, Germany
¹²Oslo University Hospital, Rikshospitalet, Clinic for Cancer Medicine, Hematology Department, Section for Stem Cell Transplantation, Oslo, Norway
¹³Service d'Hématologie Clinique et Thérapie Cellulaire, CHU Bordeaux, Pessac, France
¹⁴Faculty of Medicine, Medical University of Silesia in Katowice, Katowice, Poland
¹⁵University of Muenster, Muenster, Germany
¹⁶Department of Hematology, Gustave Roussy Cancer Campus, Villejuif, France
¹⁷Department of Internal Medicine, Bone Marrow Transplantation Unit, University Hospital of Patras, Patras, Greece
¹⁸Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN
¹⁹Sorbonne Université Service d' Hématologie Clinique et Thérapie Cellulaire, Hospital Saint-Antoine, Centre de Recherche Saint-Antoine (CRSA), Paris, France
²⁰IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy
²¹Saint-Antoine Hospital, Sorbonne University, Paris, France
²²Hôpital Saint Antoine, Paris, FRA

Asad Bashey, MD, PhD¹, Xu Zhang, PhD^2*, Lawrence Morris, MD¹, Kent Holland, MD^1*, Lizamarie Bachier-Rodriguez, MD^1*, Melhem M. Solh, MD¹ and Scott R. Solomon, MD¹

¹BMT Program at Northside Hospital, Atlanta, GA
²Center for Clinical and Transitional Sciences,, University of Texas, Houston, TX

Kyoko Fuse, MD, PhD¹, Tatuya Suwabe, MD, PhD^2*, Takayuki Katagiri, MD, PhD^3*, Yasuhiko Shibasaki, MD, PhD^3*, Hirohito Sone, MD, PhD^3* and Masayoshi Masuko, MD, PhD²

¹Department of Transfusion Medicine, Cell Therapy and Regenerative Medicine, Niigata University Medical and Dental Hospital, Niigata, Japan
²Department of Haematopoietic Cell Therapy, Niigata University Medical and Dental Hospital, Niigata, Japan
³Niigata University Faculty of Medicine, Niigata, Japan

Shufen Wang, PhD^1,2*, He Huang^3,4,5* and Haowen Xiao^1,2*

¹Department of Hematology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
²Institute of Hematology, Zhejiang University, Hangzhou, China
³Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China
⁴The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China., Hangzhou, China
⁵Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, China

Niketa C. Shah, MD¹, Alexander I. Ngwube, MD^2*, David A Jacobsohn, MD³ and Shalini Shenoy, MD, MBBS⁴

¹Department of Pediatric Hematology Oncology and Stem Cell Transplant, Yale New Haven Children’s Hospital, Yale University, New Haven, CT
²Phoenix Children's Hospital, Phoenix, AZ
³Children's National Medical Center, Washington, DC
⁴Washington University Medical Center, Saint Louis, MO

Mohammed El Anbari^1*, Merav Bar^2*, Mohammed Toufiq^1*, Darawan Rinchai^1*, Dhanya Kizhakayil^1*, Irene Cavattoni^3*, Nikolett Lupsa^4*, Phuong T Vo, MD⁵, Sara Tomei^1*, Ayman Saleh^1*, Chiara Cugno¹, Annalisa Terranegra^1*, Zoltan Pos^4*, Damien Chaussabel^1* and Sara Deola^1*

¹Sidra Medicine, Doha, Qatar
²Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
³Hematology and BMT, General Hospital, Bolzano, ITA
⁴Department of Genetics, Cell and Immunobiology, Semmelweis University, Budapest, Hungary
⁵Clinical Research Division, Fred Hutch Cancer Center; and Division of Oncology, University of Washington, Seattle, WA

Rima M. Saliba, PhD^1*, Curtis Marcoux, MD, MSc^2*, Amin Alousi^1*, Gabriela Rondon, MD¹, Julianne Chen^1*, May Daher, MD¹, Richard E. Champlin, MD¹, Katy Rezvani, MD¹, Elizabeth J. Shpall, MD¹ and Rohtesh S. Mehta, MD³

¹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
²Division of Hematology, Dalhousie University, Halifax, NS, Canada
³Clinical Research Division, Fred Hutchinson Cancer Center, Houston, TX

Guillermo Orti, MD, PhD^1*, Christophe Peczynski, MSc^2*, Christian Koenecke, MD³, William Boreland^4*, Maeve O'Reilly^5*, Martin Bornhäuser, MD^6*, Adriana Balduzzi⁷, Caroline Besley, MD^8*, Krzysztof Kalwak^9*, Samppa Ryhanen Sr., MD, PhD¹⁰, Tayfun Güngör, MD^11*, Robert F. Wynn, MRCP, MD, FRCPath^12*, Peter Bader, MD, PhD¹³, Stephan Mielke, MD¹⁴, Didier Blaise, MD, PhD¹⁵, Persis Amrolia, FRCP, FRCPath, PhD^16*, Ibrahim Yakoub-Agha, MD, PhD^17*, Friso G. J. Calkoen, MD¹⁸, Maria-Luisa Schubert, MD^19*, Victoria Potter^20*, Wolfgang Holter, MD^21*, Nicolaus Kröger, MD^22*, Mi Kwon²³, Henrik Sengeloev^24*, Helene Schoemans, MD^25*, Ivan Sergeevich Moiseev, MD^26*, Olaf Penack, MD^27* and Zinaida Peric, MD PhD^28*

¹Vall D' Hebron University Hospital, Barcelona, Spain
²EBMT Paris study office / CEREST-TC, Hôpital Saint Antoine, Sorbonne University, Paris, France
³Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, NDS, Germany
⁴EBMT Paris Study Unit, Paris, France
⁵Department of Haematology, University College London Hospitals, London, United Kingdom
⁶Department of Internal Medicine 1, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany
⁷Pediatric Hematopoietic Transplant Unit, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy, School of Medicine and Surgery, Milano-Bicocca University, Milan, Italy
⁸Department of Haematology, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom
⁹Department of Pediatric Hematology Oncology and BMT, Wroclaw Medical University, Wroclaw, Poland
¹⁰Hospital For Children and Adolescent, Helsinki University Central Hospital, Helsinki, FIN
¹¹University Children's Hospital, Zürich, Switzerland, Zürich, Switzerland
¹²Royal Manchester Children's Hospital, Manchester, GBR
¹³Division for Stem Cell Transplantation and Immunology, University Children's Hospital Frankfurt, Frankfurt, Germany
¹⁴Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska Institute & University Hospital, Stockholm, Stockholms Laen, Sweden
¹⁵Program of Transplant and cellular immunotherapy, Department of Hematology, Institut Paoli Calmettes, Marseille, France
¹⁶Great Ormond Street Children’s Hospital, London, United Kingdom
¹⁷CHU de Lille, Université de Lille, INSERM U1286, Infinite, 59000, Lille, France
¹⁸Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands
¹⁹University of Heidelberg, Heidelberg, Heidelberg, DEU
²⁰Department of Haematological Medicine, King's College Hospital NHS, London, United Kingdom
²¹St.Anna Children's Hospital, Vienna, Vienna, AUT
²²University Hospital Eppendorf, Bone Marrow Transplantation Centre, Hamburg, Germany
²³General University Hospital Gregorio Marañón, Madrid, Spain
²⁴Rigshospitalet, Copenhagen, Denmark
²⁵Department of Hematology,Department of Public Health and Primary Care, ACCENT VV, University Hospitals Leuven, KU Leuven - University of Leuven, Leuven, Belgium
²⁶St Petersburg University, St Petersburg, Russian Federation
²⁷Department of Hematology, Oncology, and Cancer Immunology, Charité Universitätsmedizin Berlin, Campus Virchow Klinik, Berlin, Germany
²⁸University Hospital Center Rebro, Zagreb, Croatia

Mary Mansour Riwes, DO¹, Jonathan Louis Golob, MD, PhD^1*, John M. Magenau, MD^1*, Costas Lyssiotis, Ph.D.^1*, Mengrou Shan^1*, Gregory Dick, PhD^1*, Thomas Braun^1*, Thomas M Schmidt^1*, Attaphol Pawarode, MD¹, Sarah Anand, MD¹, Monalisa Ghosh, MD¹, John Maciejewski, MD, PhD¹, Darren King^1*, Sung W. Choi, MD, MS¹, Gregory Yanik, MD^1*, Marcus Johannes Geer, MD¹, Ethan Hillman^1*, Muneesh Tewari^1* and Pavan Reddy, MD^2,3

¹Rogel Cancer Center, University of Michigan, Ann Arbor, MI
²Rogel Cancer Center, University of Michigan, Houston, TX
³Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston

Susumu Tanoue^1*, Hiroki Yokoyama, MD, PhD^2*, Hiroto Ishii, MD, PhD^3*, Daiki Hattori, MD^2*, Iku Kamitani^2*, Takeshi Saito, MD, PhD² and Shingo Yano, MD, PhD²

¹Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Kashiwa-Shi, CHI, Japan
²Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
³The Jikei University Hospital, Minato-ku, Tokyo, Japan

Pongthep Vittayawacharin, MD^1,2*, Deepa Jeyakumar, MD¹, Benjamin J. Lee, PharmD^3*, Jean Doh, PharmD^3*, Shawn Griffin, PharmD^3,4*, Richard A. Van Etten, MD, PhD¹, Piyanuch Kongtim, MD PhD^1* and Stefan Ciurea, MD¹

¹Hematopoietic Stem Cell Transplantation and Cellular Therapy Program, Division of Hematology/Oncology, Department of Medicine, University of California Irvine, Orange, CA
²Division of Hematology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
³Department of Pharmacy, University of California Irvine, Orange, CA
⁴Department of Clinical Pharmacy Practice, School of Pharmacy & Pharmaceutical Sciences, University of California Irvine, Orange, CA

Scott R. Solomon, MD¹, Melhem M. Solh, MD¹, Asad Bashey, MD, PhD¹, Lizamarie Bachier-Rodriguez, MD^1*, Xu Zhang, PhD^2*, Lawrence Morris, MD¹ and H. Kent Holland, MD^1*

¹Blood and Marrow Transplant Program, Northside Hospital Cancer Institute, Atlanta, GA
²Center for Clinical and Transitional Sciences,, University of Texas, Houston, TX

Xueyan Sun^*, Qingyuan Qu^*, Yuxiu Chen^*, Menglin Li^*, Fengqi Liu^*, Qi Chen, MD^*, Haixia Fu, MD^*, Xiaohui Zhang, MD^* and Xiangyu Zhao, M.D, Ph.D

Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China

Xinhui Zheng^1*, Xin Chen^2* and Erlie Jiang, PhD²

¹Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
²State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, Tianjin, China

Madlen Reschke, MD^1,2*, Jonathan P. Gross, MD^1,2, Olaf Penack, PhD^3*, Gülüstan Sürücü, MD^4*, Corinne Summers, MD^5*, Jonas Seiler, M.Sc.^1*, Daniel Weschke, M.Sc.^1,2*, David Higgins, PhD^1* and Lena Oevermann, PhD^1,2*

¹Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Berlin, Germany
²Department of Pediatric Oncology & Hematology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
³Department of Hematology, Oncology and Tumorimmunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
⁴Institute of Transfusion Medicine, H&I Laboratory, Charité-Universitätsmedizin Berlin, Berlin, Germany
⁵Fred Hutchinson Cancer Research Center, Seattle, WA

Michael Pratta^1*, Angelina Volkova^1*, Maureen Bleam^1*, Rodica Morariu-Zamfir^1*, Beth Rumberger^1*, Stephen Douglass^1*, Susan H. Smith^1*, Valkal Bhatt^1*, John Galvin¹, Annie Im², Sophie Paczesny³, Kirk R. Schultz⁴ and Steven Z. Pavletic⁵

¹Incyte Corporation, Wilmington, DE
²University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh, PA
³Medical University of South Carolina, Charleston, SC
⁴University of British Columbia, Vancouver, BC, Canada
⁵National Cancer Institute-NIH, Bethesda, MD

Jonathan U. Peled, MD, PhD¹, Marcel R.M. van den Brink², Doris M. Ponce, MD, MS¹, Satyajit Kosuri, MD^3*, Nandita Khera, MD⁴, Zachariah DeFilipp⁵, Bina Tejura, MD^6*, David I Lichter, ALM^6*, Mary-Jane Lombardo, PhD^6*, Meghan Chafee, PhD^6*, Jennifer R Wortman, MSc^6*, Timothy Straub, MSc^6*, Emily Walsh, PhD^6*, Augustus Ge, MA^6*, David Lyttle, PhD^6*, Brooke Hasson, PhD^6*, Christopher Ford, PhD^6*, Lisa von Moltke, MD^6* and Matthew Henn, PhD^6*

¹Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Medicine, Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY
³University of Chicago Medicine, Chicago, IL
⁴Mayo Clinic, Phoenix, AZ
⁵Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA
⁶Seres Therapeutics, Cambridge, MA

Mihee Kim, MD^1*, Seo-Yeon Ahn, MD^1*, Sung-Hoon Jung^1*, Ga-Young Song^1*, Deok-Hwan Yang, MD, PhD^1*, Je-Jung Lee^1*, Mi Yeon Kim^2*, Hyeoung Joon Kim, MD, PhD^1,2 and Jae-Sook Ahn, MD, PhD^1,2*

¹Hematology-Oncology, Chonnam National University Hwasun Hospital, Hawsun, Jeollanam-do, Korea, Republic of (South)
²Genomic Research Center for Hematopoietic Diseases, Chonnam National University Hwasun Hospital, Hawsun, Jeollanam-do, Korea, Republic of (South)

Beatriz Merchán Muñoz, MD^1*, Paola Charry, MD^2*, Tommaso Francesco Aiello, MD^3*, Pedro Puerta-Alcalde, MD^3*, Maria Teresa Solano^2*, Mariana Chumbita^3*, Patricia Monzo^3*, Laura Rosiñol, MD, PhD^2,4,5,6,7*, Alexandra Martínez-Roca, MD^8*, Alexandra Pedraza, MD^2*, Joan Cid, MD, PhD^2,9*, Meritxell Nomdedeu, MD^2*, Enric Carreras^10*, Alvaro Urbano-Ispizua Sr., MD^2,11,12, Jordi Esteve, MD, PhD^2,13, Carolina Garcia-Vidal^3*, Carmen Martínez^14*, Francesc Fernández-Avilés, MD^15*, Montserrat Rovira, MD, PhD^15*, Maria Suarez-Lledo, MD, PhD^15* and Maria Queralt Salas^2*

¹Hematology Department, Hospital Clinic de Barcelona, ICMHO, Barcelona, Spain, Barcelona, Spain
²Hematopoietic Cell Transplantation Unit, Hospital Clínic de Barcelona, ICHMO, Barcelona, Spain
³Hospital Clinic Barcelona, Barcelona, Spain
⁴Hospital Clinic de Barcelona, IDIBAPS, Barcelona, Spain
⁵Amyloidosis and Multiple Myeloma Unit, Department of Hematology, IDIBAPS, Hospital Clinic, Barcelona, Spain
⁶Amyloidosis and Myeloma Unit, Hospital Clinic, IDIBAPS, Barcelona, Spain
⁷Hematopoietic Cell Transplantation Unit,, Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain
⁸Hematology Department, Hospital Clinic de Barcelona, ICMHO, Barcelona, Spain
⁹Hospital Clinic de Barcelona, IDIBAPS., Barcelona, Spain
¹⁰Josep Carreras Foundation & Leukemia Research Institute, Barcelona, Spain
¹¹Department of Hematology, Hospital Clínic, Barcelona, Barcelona, Spain
¹²Department of Hematology. Hospital Clinic de Barcelona. IDIBAPS. Universidad de Barcelona., Barcelona, Spain
¹³Hematology Department, Hospital Clínic Barcelona, Barcelona, Spain
¹⁴Hematology Department, Hospital Clinic, Barcelona, Spain
¹⁵Hospital Clínic de Barcelona, Barcelona, Spain

Kaibo Yang^1*, Fen Huang^2*, Jing Du^3*, Li Xuan^4*, Na Xu^4*, Zhiping Fan^5* and Qifa Liu, MD⁵

¹Department of Hematology, Nanfang Hospital,Southern Medical University, Guangzhou, China
²Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, CHN
³Department of Hematology, Nanfang Hospital, Southern Medical University, GUANGZHOU, CHN
⁴Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
⁵Nanfang Hospital, Southern Medical University, Guangzhou, China